Breaking News Instant updates and real-time market news.

CMG

Chipotle

, UNG

United States Natural Gas Fund

09:40
06/20/17
06/20
09:40
06/20/17
09:40

Unusually active option classes on open June 20th

Unusual total active option classes on open include: Chipotle (CMG), UNG (UNG), AMD (AMD), Comcast (CMCSA), FXI (FXI), Costco (COST), Whole Foods (WFM), NVIDIA (NVDA), Chesapeake (CHK), and Rite Aid (RAD).

CMG

Chipotle

UNG

United States Natural Gas Fund

AMD

AMD

$11.93

0.49 (4.28%)

CMCSA

Comcast

$41.80

0.52 (1.26%)

FXI

iShares China Large-Cap ETF

$39.96

1.6E-5 (0.00%)

COST

Costco

$164.34

-2.77 (-1.66%)

WFM

Bought by AMZN

$43.22

0.54 (1.27%)

NVDA

Nvidia

$157.32

5.7 (3.76%)

CHK

Chesapeake

RAD

Rite Aid

  • 22

    Jun

  • 26

    Jun

  • 27

    Jul

  • 15

    Aug

  • 23

    Aug

  • 29

    Aug

CMG Chipotle

06/20/17
FBCO
06/20/17
NO CHANGE
Target $425
FBCO
Neutral
Chipotle estimates lowered at Credit Suisse after guidance
Credit Suisse analyst Jason West noted that Chipotle's updated guidance on Q2 food costs and other operating expenses was unfavorable and he cut his Q2 earnings forecast to well-below consensus at $2.00 per share. West maintains his Neutral rating and $425 price target on Chipotle shares.
06/20/17
DBAB
06/20/17
NO CHANGE
Target $300
DBAB
Sell
Chipotle margin recovery remains under pressure,' says Deutsche Bank
Deutsche Bank analyst Brett Levy says Chipotle Mexican Grill's costs continue to weigh on unit-level performance after management last night explained certain unit-level costs in a regulatory filing. Elevated food costs, incremental marketing spending and other operating expenses continue to weigh on restaurant-level profits, Levy tells investors in a research note. He lowered his Q2 earnings per share estimate by 20c to $2.04 and keeps a Sell rating on Chipotle.
06/20/17
NOMU
06/20/17
NO CHANGE
Target $480
NOMU
Neutral
Chipotle price target lowered to $480 from $510 at Nomura Instinet
Nomura Instinet analyst Mark Kalinowski lowered Chipotle's price target to $480 from $510 following management commentary that indicates margin pressure in Q2. Management now expects Q2 other operating costs to be higher than in Q1, contributing to the analyst's reduction in 2017 earnings estimate to $8.30 from $8.75, and 2018 earnings estimate to $12 from $12.75. Kalinowski rates Chipotle an Equal Weight.
06/20/17
MAXM
06/20/17
NO CHANGE
Target $440
MAXM
Hold
Chipotle estimates reduced after cost comments at Maxim
Maxim analyst Stephen Anderson noted that Chipotle management alluded to higher costs incurred during the quarter in commentary released ahead of the company's planned presentations at investor conferences this week. Given the new guidance, Anderson lowered his earnings estimate for Q2, though he maintains his expectations for a double-digit comparable sales increase. The analyst keeps a Hold rating and $440 price target on Chipotle shares.
UNG United States Natural Gas Fund

AMD AMD
$11.93

0.49 (4.28%)

06/12/17
GSCO
06/12/17
NO CHANGE
Target $10.6
GSCO
Sell
AMD GPU demand from cryptocurrency mining unsustainable, says Goldman Sachs
Goldman Sachs analyst Toshiya Hari said AMD share strength last week related to reports of GPU demand from cryptocurrency miners may provide near-term upside to fundamentals, but is not a sustainable driver. Hari said rising cryptocurrency prices does not equate to sustainable GPU growth, ASP expansion, or sustainable share gains. The analyst believes sharse are already pricing in significance market share improvement and bottom-line profitability and would Sell the shares given 14% potential downside to his price target of $10.60.
06/09/17
RBCM
06/09/17
NO CHANGE
Target $175
RBCM
Outperform
RBC ups Nvidia target to $175 on data center confidence
To reflect confidence in the company's Data Center opportunity and the potential for upside revisions to consensus earnings estimates, RBC Capital analyst Mitch Steves raised his price target for Nvidia (NVDA) shares to $175 from $150. The chipmaker in afternoon trading is down 6%, or $10.13, to $149.81. With 192% year-over-year growth, the Data Center segment, along with virtual reality, offers the "potential for robust growth," Steves tells investors in a research note. The analyst also provided an overview of the cryptocurrency mining market. As of today, mining is profitable for cryptocurrency Ethereum, making demand outstrip supply, the analyst writes. He points out that AMD (AMD) GPUs are currently selling at a premium, suggesting that more GPUs sold by AMD were used for mining relative to Nvidia. The analyst cautions, however, that the total addressable market for GPU cryptocurrency "could go to zero overnight" if the prices of the cryptocurrencies fall. Steves has an Outperform rating on Nvidia with an upside scenario case of $250 per share and downside scenario case of $80.
05/22/17
SBSH
05/22/17
NO CHANGE
Target $4
SBSH
Sell
AMD licensing deal with Intel is unlikely, says Citi
Citi analyst Christopher Danely points out that Fudzilla last week published an article claiming that Intel (INTC) had signed a licensing agreement with AMD (AMD) for use of AMD's GPU intellectual property. AMD made no mention of such an agreement at its analyst day and Intel subsequently denied the story, Danely tells investors in a research note. He believes such a deal is unlikely and reiterates a Sell rating on AMD with a $4 price target.
06/16/17
MSCN
06/16/17
NO CHANGE
MSCN
AMD flagship GPU checks positive, says MScience
CMCSA Comcast
$41.80

0.52 (1.26%)

04/26/17
FBCO
04/26/17
NO CHANGE
Target $37
FBCO
Outperform
Hulu stake could be for sale this year, says Credit Suisse
Credit Suisse analyst Omar Sheikh notes that Comcast (CMCSA; CMCSK) will be free to sell its 30% stake in Hulu from the end of 2017. The analyst believes there is a $100B domestic revenue opportunity for targeted TV advertising long-term, which vertically integrated networks/distributors will be in a strong position to exploit. Therefore, Sheikh argues that it would make sense for 21st Century Fox (FOX; FOXA) to acquire Comcast's stake in Hulu, if it becomes available, subject to valuation and appropriate programming supply agreements. He reiterates an Outperform rating and $37 price target on 21st Century Fox's shares.
05/30/17
PIPR
05/30/17
NO CHANGE
Target $25
PIPR
Overweight
Piper sees increased likelihood of Tivo, Comcast renewal
Piper Jaffray analyst Michael Olson believes Friday's International Trade Commission ruling in favor of TiVo (TIVO) increases the likelihood that a deal with Comcast (CMCSA) will ultimately be reached. The analyst, who has not baked a Comcast renewal into his estimates until early 2018, reiterates an Overweight rating on TiVo with a $25 price target.
05/30/17
COWN
05/30/17
NO CHANGE
Target $30
COWN
Outperform
TiVo shares significantly undervalued, says Cowen
Cowen analyst Robert Stone believes TiVo (TIVO) shares are poised for significant upside; as much as roughly 80%. He noted the initial U.S. ITC determination found a violation by Comcast (CMCSA) of two TiVo patents and expects that Hulu infringes on even more TiVo IP. Stone reiterated his Outperform rating and $30 price target on TiVo shares.
06/20/17
MOFT
06/20/17
DOWNGRADE
MOFT
Neutral
Comcast downgraded to Neutral from Buy at MoffettNathanson
MoffettNathanson analyst Craig Moffett downgraded Comcast to Neutral and cut the Cable sector to Neutral saying stocks have had a multi-year bull run and air fairly valued.
FXI iShares China Large-Cap ETF
$39.96

1.6E-5 (0.00%)

COST Costco
$164.34

-2.77 (-1.66%)

06/20/17
NRCS
06/20/17
UPGRADE
NRCS
Buy
Costco upgraded to Buy from Neutral at Northcoast
06/20/17
06/20/17
UPGRADE
Target $190

Buy
Costco upgraded to Buy, business model remains strong, says Northcoast
As previously reported, Northcoast upgraded Costco to Buy from Neutral with a $190 price target. Analyst Chuck Cerankosky said the firm's Retail Momentum Index has strengthened for Costco and expects earning to benefit from fiscal 2018 by membership fee increases that took effect on June 1. The analyst said Costco is able to combine value merchandising with an upscale product selection in a destination shopping format, is taking market share in fresh food categories, and is shown to be relatively immune to food deflation over the past several quarters.
06/19/17
RBCM
06/19/17
NO CHANGE
RBCM
Wal-Mart, Costco could be hurt by Whole Foods deal, says RBC Capital
RBC Capital analyst Scot Ciccarelli warns that Wal-Mart (WMT) and Costco (COST) could be hurt by the Whole Foods deal. The analyst says that "combining Whole Foods' high-end reputation with a logistics juggernaut like Amazon is clearly a danger" to Costco and Walmart. He thinks that Whole Foods could extend the hours in which it allows customers to buy products online and pick them up in stores, and he thinks that food delivery could become much more popular in the wake of the deal. He notes that Wal-Mart has spent a great deal of time and money on "improving its fresh and omni-channel offerings." The analyst says that Costco will be more protected due to what he sees as its "differentiated retail experience."
06/19/17
06/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Costco (COST) downgraded to Hold from Buy at Deutsche Bank with analyst Paul Trussell saying positive pipeline catalysts have played out while competition is intensifying with Amazon.com (AMZN) and Wal-Mart (WMT) accelerating in-store and online efforts. The analyst lowered his price target for the shares to $172 from $187. 2. Kroger (KR) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Vincent Sinisi saying there is increased structural margin risk within the Food Retail sector following Amazon's (AMZN) acquisition of Whole Foods (WFM) and said stocks are now appropriately pricing in flat medium-term growth. 3. Wayfair (W) downgraded to Hold from Buy at Maxim with analyst Tom Forte saying he views the current share price as fully reflecting its revenue growth opportunity over the next three years and his expectation that the company can meet the top-end of its long-term adjusted EBITDA margin target of 8%-10%. 4. Travelers (TRV) downgraded to Neutral from Buy at BofA/Merrill with analyst Jay Cohen citing valuation. 5. TripAdvisor (TRIP) downgraded to Underperform from Neutral at Credit Suisse with analyst Paul Bieber citing raised expectations for TV ad spending in 2018 paired with uncertainty regarding the return on TV advertising investment given the crowded ad market for online travel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WFM Bought by AMZN
$43.22

0.54 (1.27%)

06/19/17
PIVT
06/19/17
UPGRADE
Target $42
PIVT
Hold
Whole Foods upgraded to Hold from Sell at Pivotal Research
06/19/17
PIVT
06/19/17
NO CHANGE
Target $32
PIVT
Sell
Amazon could renegotiate or terminate United Natural contract, says Pivotal
Pivotal Research analyst Ajay Jain said regardless of the change of control provisions under United Natural Foods' (UNFI) contract with Whole Foods (WFM), there is no way to characterize the acquisition by Amazon (AMZN) as a non-event. Based on Albertson's United Foods contract cancellation in 2015, the analyst believes it will not be difficult for Amazon to renegotiate or terminate the United Natural Foods contract, if it so pleases. Jain said Whole Foods has more leverage over United Natural and the ability to demand further pricing concessions and will have more control over the supply chain through Amazon, making it unlikely the current agreement is truly binding. Jain rates United Natural Foods a Sell with a $32 price target.
06/20/17
LOOP
06/20/17
NO CHANGE
Target $45
LOOP
Hold
Amazon buying RH a 'future possibility,' says Loop Capital
Loop Capital analyst Anthony Chukumba believes Amazon.com (AMZN) acquiring RH (RH) is a "future possibility." The tech giant's acquisition of Whole Foods (WFM) shows a willingness to acquire traditional brick-and-mortar retailers, Chukumba tells investors in a research note titled "Should Amazon Acquire RH?" A potential takeover by Amazon is a not a compelling reason to buy RH, but the possibility of a deal could provide a "floor" on the stock, the analyst argues. At a $70 per share RH takeover price, the analyst sees the deal being 15c, or 1.4%, accretive to the current consensus FY18 diluted earnings per share estimate for Amazon. Amazon could afford to "pay significantly more" for RH and still have the deal be earnings accretive, Chukumba contends. He maintains a Hold rating on RH with a $45 price target. The home furnishings retailer closed yesterday at $53.47.
06/19/17
KEYB
06/19/17
NO CHANGE
KEYB
Wal-Mart outlook still positive after Whole Foods deal, says KeyBanc
KeyBanc says that Wal-Mart (WMT) stock should be bought in the wake of the Whole Foods (WFM) deal, as the firm remains confident in Wal-Mart's ability to achieve 5%-9% earnings growth in fiscal 2018. The analyst says that the market shares of both Amazon and Wal-Mart have room to grow, and it believes that Amazon will continue to skew towards upper class Americans in the wake of the Whole Foods deal. The firm keeps a $90 price target and an Outperform rating on Wal-Mart.
NVDA Nvidia
$157.32

5.7 (3.76%)

06/15/17
RAJA
06/15/17
INITIATION
Target $175
RAJA
Outperform
Nvidia resumed with an Outperform at Raymond James
Raymond James analyst Chris Caso resumed coverage on Nvdia with an Outperform and a $175 price target saying valuation is being driven by long-term Datacenter and Auto potential and shares should continue higher if those segments continue to advance and the core business remains stable.
06/20/17
PACS
06/20/17
UPGRADE
PACS
Sector Weight
Nvidia upgraded to Sector Weight from Underweight at Pacific Crest
Pacific Crest analyst Michael McConnell upgraded Nvidia to Sector Weight after Asia supply-chain channel checks left him "incrementally more positive." Strong GPU demand from the cryptocurrency mining market has "rapidly depleted excess channel inventory" carried into Q2 and reduces gaming segment growth concerns in FY18, McConnell tells investors in a research note.
06/15/17
WELS
06/15/17
NO CHANGE
WELS
Nvidia likely to encounter competition in accelerators, says Wells Fargo
Wells Fargo believes that "several different classes of (datacenter) accelerators" will emerge. The firm says that Nvidia's accelerators "are optimized for some specific types of applications" i.e. graphics or image processing,leaving the door open for processors that are stronger in other areas. Wells keeps an Underperform rating on Nvidia.
06/20/17
PACS
06/20/17
DOWNGRADE
PACS
Sector Weight
ON Semiconductor downgraded to Sector Weight from Overweight at Pacific Crest
Pacific Crest analyst Michael McConnell downgraded ON Semiconductor (ON) to Sector Weight after Asia supply-chain channel checks left him "incrementally more cautious." Signs of double-ordering by customers raises risk of a correction over the next 12 months, McConnell tells investors in a research note. He recommends investors move to the sidelines with respect to the shares. The analyst this morning also upgraded Nvidia (NVDA) to Sector Weight and Marvell Technology (MRVL) to Overweight.
CHK Chesapeake

04/19/17
EVER
04/19/17
NO CHANGE
Target $8
EVER
In Line
Chesapeake added to Tactical Outperform List at Evercore ISI
Evercore ISI analyst Stephen Richardson added Chesapeake Energy to the Tactical Outperform List saying shares have fallen 20% year-to-date and expectations have been reset. Richardson expects corporate production to trough in April and rise the balance of 2017 and said incremental well results from the PRB and Anadarko basin to be potentially supportive for the stock and drive the market's view of asset value potentially higher. The analyst has rates shares an In Line with an $8 price target.
06/15/17
WOLF
06/15/17
INITIATION
Target $5.5
WOLF
Peer Perform
Chesapeake initiated with a Peer Perform at Wolfe Research
Wolfe Research initiated Chesapeake with a Peer Perform and a $5.50 price target.
05/11/17
BOFA
05/11/17
DOWNGRADE
Target $8
BOFA
Underperform
Chesapeake downgraded to Underperform, leverage too much, says BofA/Merrill
As previously reported, BofA/Merrill downgraded Chesapeake to Underperform from Neutral and lowered its price target to $8 from $11. Analysts led by Doug Leggate said oil markets are taking longer to recover and Chesapeake retains little upside from current strip prices and still has too much leverage if long-term oil and gas prices remain weak.
05/11/17
BOFA
05/11/17
DOWNGRADE
BOFA
Underperform
Chesapeake downgraded to Underperform from Neutral at BofA/Merrill
RAD Rite Aid

05/31/17
COWN
05/31/17
NO CHANGE
Target $5
COWN
Outperform
Cowen believes Walgreens will pursue Rite Aid even if FTC acts to block merger
Cowen analyst Charles Ryhee said the FTC decision on the merger between Walgreens (WBA)and Rite Aid (RAD) is too difficult to call, but he believes although Rite Aid will struggle on its own its value to Walgreens is significant. He also believes the value is well above the deal price range and so expects Walgreens will litigate the decision in an attempt to win an approval. Ryhee reiterated his Outperform rating but lowered his price target to $4.70 from $6.75 on Rite Aid shares.
05/31/17
JEFF
05/31/17
NO CHANGE
Target $95
JEFF
Buy
Walgreens has upside with or without Rite Aid, says Jefferies
Jefferies analyst Brian Tanquilut believes shares of Walgreens Boots Alliance (WBA) have upside with or without the successful closing of the Rite Aid (RAD) acquisition. If the FTC blocks the deal, Walgreens is likely to put through a "sizeable" repurchase, Tanquilut tells investors in a research note. If the deal is approved, the analyst continues to expect earnings accretion beginning in 2018. The analyst finds it "difficult to handicap the odds" of an FTC approval. Nonetheless, he remains a buyer of Walgreens at current share levels. Tanquilut has a Buy rating on the name with a $95 price target.
06/13/17
BARD
06/13/17
NO CHANGE
Target $96
BARD
Outperform
Walgreens Boots Alliance Q3 results will include deal contingencies, says Baird
Baird analyst Eric Coldwell noted Walgreens Boots Alliance (WBA) will report Q3 results on June 29 and its focus will be on ramping wins in the U.S. and the start of Alliance Rx. He also believes there will be an update on the Rite Aid (RAD) deal and although he would prefer the deal to close, he is prepared for contingency plans, which may include a stock buyback. Coldwell maintained his Outperform rating and $96 price target on Walgreens shares.
04/25/17
GUGG
04/25/17
DOWNGRADE
GUGG
Neutral
Rite Aid downgraded to Neutral from Buy at Guggenheim

TODAY'S FREE FLY STORIES

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$204.65

1.99 (0.98%)

16:57
09/22/17
09/22
16:57
09/22/17
16:57
Hot Stocks
Allergan receives refusal to file letter from FDA for Vraylar »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

HON

Honeywell

$141.75

0.89 (0.63%)

, CC

Chemours

$51.79

-0.16 (-0.31%)

16:51
09/22/17
09/22
16:51
09/22/17
16:51
Hot Stocks
Honeywell, Chemours seek rehearing of D.C Court decision regarding SNAP program »

Honeywell (HON) and…

HON

Honeywell

$141.75

0.89 (0.63%)

CC

Chemours

$51.79

-0.16 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOE

Saint Joe Co.

$18.60

0.45 (2.48%)

16:46
09/22/17
09/22
16:46
09/22/17
16:46
Hot Stocks
Breaking Hot Stocks news story on Saint Joe Co. »

Fairholme raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
09/22/17
09/22
16:40
09/22/17
16:40
General news
Moody's downgrades UK's rating to Aa2, changes outlook to stable »

Moody's Investors…

A

Agilent

$65.78

-0.14 (-0.21%)

, MRK

Merck

$65.13

-0.47 (-0.72%)

16:36
09/22/17
09/22
16:36
09/22/17
16:36
Hot Stocks
Agilent receives expanded FDA approval for the use of Dako PD-L1 IHC 22C3 »

Agilent Technologies…

A

Agilent

$65.78

-0.14 (-0.21%)

MRK

Merck

$65.13

-0.47 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 08

    Nov

  • 30

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.